Thursday, April 10, 2008
On with the show
OK, you win. I shall share the harrowing tale of the Aardvark as guinea pig.
(Does anyone know the Japanese word for "aardvark"?)
The clinical trial investigates the efficacy of a drug that is currently on the market as an agent to fight certain cancers in women. Its mechanism inhibits hormone production.
The idea is to see if this will work in men, resulting in the reduction of prostate size in cases of benign prostate hyperplasia (BPH).
My doctor (Dr. N.) is a woman, a neat person, but had to use the word "castration" twice in the interview (in that the diminution of testosterone would not be at "castration levels"). So, this drug will inhibit my body's production of testosterone, which will reduce the size of my prostate (assuming that it has done as is normal in my family line, and grown to gamma-induced proportions. HULK SMASH!), which will in turn keep me in bed at night, rather than trotting to the bathroom. This is made of WIN, as the kids say now.
Unfortunately, the staying in bed may not be as advantageous as one might think. One of the side-effects of the treatment may be the reduction of my libido. The percentage is surprisingly low, but still possible, as is the other possibility of aggression being a side-effect. Wow, color me an Attack-'vark. This is one of the reasons I want to keep this journal, so as not to become insular. You will be outsiders with white lab coats and stainless-steel clipboards, and those neat astronaut pens that can write in microgravity.
You can make "ahem" noises if I seem too wiggy, or go silent.
Or you know, this could be the most boring thing ever, except for the shots.
Oh yes. There will be shots.